From: Late presentation of sorafenib-associated rash: a case report
POINTS
0
1
Tumor size
<50% liver
>50% liver
Ascites
No
Yes
Albumin (g/dL)
≥3
<3
Bilirubin (mg/dL)
Okuda Stage
Points
I
II
1-2
III
3-4